. Here, we show that the RTG pathway is activated when a hypophos-first tested whether overexpression of Mks1p could downregulate the pathway to the extent that cells would become starved for glutamate. Wild-type cells overexpressing full-length Mks1p under the control of the ADH1 promoter are glutamate auxotrophs ( Figure 1A) , suggesting that the RTG pathway is downregulated. To verify that conclusion and to determine the functional domains of Mks1p, we created a series of truncated N-and C-terminal Mks1p fragments ( Figure 1B ) whose expression in centromeric plasmids was placed under the control of the ADH1 promoter. The expression levels of these Mks1p fragments and full-length Mks1p with a C-terminal (HA) 3 tag were examined by Western blot analysis and found to be comparable (data not shown). To provide a direct read-out of RTG-dependent gene expression, those plasmids were transformed into wild-type and mks1⌬ cells containing an integrated copy of a CIT2-lacZ reporter gene. From these experiments, we could identify a minimal N-terminal fragment, Mks1p (1-304), that, when expressed in either wild-type or mks1⌬ cells, inhibited CIT2-lacZ expression by ‫%08ف‬ ( Figures  1C and 1D ). Further truncation to Mks1p (1-275) resulted in a weaker inhibition of reporter gene expression. Similarly, we identified a minimal C-terminal fragment, Mks1p (276-584), which, when expressed in wild-type cells, inhibited CIT2-lacZ expression by ‫%07ف‬ ( Figure  1C) . Further truncated C-terminal Mks1p fragments showed weaker, or no significant inhibition of reporter gene expression in wild-type cells. Overexpression of Mks1p (245-346), which encompasses overlapping resi- (C) Rtg2p mutants have reduced ability to interact with Mks1p. rtg2⌬ cells with an integrated Mks1p-myc construct (TSY1271) were transformed individually with plasmids expressing untagged Rtg2p (pZL731), wild-type Rtg2p-HA (pZL675), mutant Rtg2-1p-HA (pZL677), mutant Rtg2-2p-HA (pZL681), or mutant Rtg2-3p-HA (pZL729). Transformants were grown in YNBcasD medium and cell extracts were prepared for immunoprecipitation as described in Experimental Procedures. Anti-myc antibody was used to pull down Mks1p-myc, and anti-HA antibody was used to detect Rtg2p-HA and its mutant derivatives. tated with Rtg2p-myc, confirming the above conclusion Interestingly, the rtg2-2 mutant was marginally better at rescuing CIT2 reporter gene expression than the other that Mks1p binds to Rtg2p through its C-terminal domain.
two Rtg2p mutants ( Figure 3B ). These data suggest that the Rtg2p mutants are defective in supporting CIT2-lacZ expression because they are compromised in their Rtg2p Point Mutants Defective in Supporting binding of Mks1p.
CIT2-lacZ Expression Are Compromised in Binding Mks1p
We next examined the effects of three point mutations
In Vivo Detection of a Dynamic Interaction between Mks1p and Rtg2p in the ATP binding domain of Rtg2p (Figure 3A) on CIT2-lacZ reporter gene expression and on the ability of those
The data presented thus far suggest that activation of RTG pathway occurs when Mks1p is bound to Rtg2p, Rtg2p mutants to interact with Mks1p. The Rtg2p mutations are located in or close to three of five highly con-and conversely, that the pathway is downregulated when Mks1p is released from Rtg2p. To provide a direct, served regions found in ATP binding proteins of this sort (Bork et al., 1992; Koonin, 1994) . None of the Rtg2p in vivo test of this hypothesis, we sought to localize Rtg2p to a specific cellular compartment, easily de-mutants could rescue CIT2-lacZ reporter gene expression to anywhere near the level observed for wild-type tected microscopically, which would then allow us to determine whether Mks1p reversibly colocalizes with Rtg2p expressed in rtg2⌬ cells ( Figure 3B ). To determine whether these Rtg2p mutants could still interact with Rtg2p under conditions that modulate RTG-dependent gene expression. To these ends, we first constructed a Mks1p, centromeric vectors encoding each of the mutants tagged at their C terminus with HA were trans-functional, C-terminal GFP-tagged derivative of Rtg2p in which the actin interacting protein, Aip1p, was fused formed into rtg2⌬ cells expressing Mks1p-myc. Extracts from these cells were immunoprecipitated with anti-myc to the C terminus of GFP. Aip1p was originally identified in a yeast two-hybrid assay as an actin interacting pro-antibody and the immunoprecipitates probed for Rtg2p-HA with anti-HA antibody. Even though wild-type and tein (Amberg et al., 1995) , and was subsequently shown to localize primarily to actin cortical patches (Rodal et mutant Rtg2p's are expressed at comparable levels, only the protein encoded by the rtg2-2 allele showed al., 1999). When we compared the intracellular localization of Rtg2p-GFP-Aip1p to that of Rtg2p-GFP alone, any significant interaction with Mks1p-HA ( Figure 3C) . the Rtg2p-GFP-Aip1p localized to punctate structures, similar to that of actin cortical patches, whereas Rtg2p-GFP was distributed in the cytoplasm ( Figure 4A ). We verified the localization of Rtg2p-GFP-Aip1p to actin cortical patches by its colocalization with phalloidinstained actin patches (data not shown).
To modulate RTG-dependent gene expression, we grew cells in the presence or absence of 0.2% glutamate. Whether glutamate was present or not, both Rtg2p-GFP and the less abundant Mks1p-GFP were distributed diffusely throughout the cytoplasm ( Figure  4B) . Similarly, the localization of Rtg2p-GFP-Aip1p to cortical patches was unaffected by the presence or absence of glutamate in the medium ( Figure 4C) ; however, when expressed in cells also expressing Rtg2p-Aip1p, Mks1p-GFP localized to cortical patches only when those cells were starved for glutamate, i.e., under conditions in which the RTG pathway was activated. Under those conditions, Ͼ70% of the cells expressing Mks1p-GFP localized to cortical patches, whereas Ͻ1% of the cells grown in the presence of glutamate showed any such punctate structures. This interaction between Rtg2p-Aip1p and Mks1p-GFP is dynamic: within 20 min after glutamate addition to glutamate-starved cells, the Mks1p-GFP cortical patches disappeared from over 90% of the cells in the population ( Figure 4D ). Finally, to show strict colocalization of Rtg2p-Aip1p and Mks1p-GFP in cells grown without glutamate in the medium, we constructed a functional Rtg2p-RFP-Aip1p derivative and expressed it in cells that were also expressing Mks1p-GFP. In this case, the vast majority of GFP and RFP fluorescence colocalized ( Figure 4E) . These results provide strong support for the hypothesis that there is a dynamic interaction between Rtg2p and Mks1p in the regulation of the RTG pathway.
A Dominant BMH1 Mutant Bypasses rtg2⌬
To search for new negative regulators of the RTG pathway, and to minimize the re-isolation of LST8 and MKS1, we used a modified RTG2 bypass screen (Liu et al., 2001) in which rtg2⌬ cells carried an extra copy of MKS1 and LST8 on a centromeric plasmid. This screen yielded a new rtg2⌬ bypass mutant, RTB3-1 (Rtg two bypass), which completely relieved the block in CIT2-lacZ ex-pRS416RTG2-GFP) were grown in YNBD medium with or without 0.2% glutamate and examined for the localization of GFP fluorescence. (C) Cells expressing Rtg2p-Aip1p target Mks1p-GFP to cortical patches only when starved for glutamate. Cells expressing Rtg2p-GFP-Aip1p (PSY142-rtg2 carrying pZL1115) and cells coexpressing Mks1p-GFP and Rtg2p-Aip1p (TSY1073 carrying pZL1123) were grown in YNBD medium with or without 0.2% glutamate. Localization of GFP fusion proteins was carried out as above. (D) Interaction between Rtg2p-Aip1p and Mks1p-GFP is reversible. pression imposed by the rtg2⌬ mutation and resulted that the RTB3-1 phenotype was due to a single gene mutation. in an activity that was three times higher than that observed in wild-type cells ( Figure 5A ). Consistent with To isolate the RTB3 gene, we constructed a genomic DNA library from the rtg2⌬ RTB3-1 strain, which was rescued expression of CIT2-lacZ, the rtg2⌬ RTB3-1 cells are glutamate prototrophs (data not shown). After cross-transformed into rtg2⌬ cells carrying a CIT2-lacZ reporter gene. Ura ϩ transformants were selected on X-gal ing wild-type, rtg2⌬ mutant, or rtg2⌬ RTB3-1 double mutants with an rtg2⌬ mutant of opposite mating type, plates, and plasmids that conferred blue color to the rtg2⌬ mutant colonies were isolated. Four different plas-the resultant diploids were examined for CIT2-lacZ activity. Reporter gene activity was abolished in rtg2⌬/ mids from among six contained overlapping genomic inserts, and only one intact ORF encoding the 14-3-3 rtg2⌬ diploids, whereas reporter gene activity was restored in rtg2⌬/rtg2⌬ RTB3-1/RTB3 diploid cells (Figure  protein, BMH1, was common, indicating that BMH1 is  RTB3. Sequencing of the BMH1-1 allele revealed a  5A) . These results indicate that the RTB3-1 mutation is dominant, and subsequent meiotic analysis indicated change of Trp233 (Trp228 in human 14-3-3 ) to a stop mutation. Together, these data indicate that BMH1 and BMH2 function redundantly as negative regulators of the RTG pathway.
Bmh1p Interacts with Mks1p 14-3-3 proteins are known to interact with phosphoproteins (Tzivion and Avruch, 2002). Because Rtg3p and Mks1p are phosphoproteins whose phosphorylation state increases when the RTG pathway is downregulated (Sekito et al., 2000) , Bmh1p or Bmh2p could interact with the more phosphorylated forms of Rtg3p or Mks1p to repress the RTG pathway. van Heusden and Steensma (2001) provided some evidence that these 14-3-3 proteins bind to denatured Rtg3p, but we have been unable to detect such an interaction by coimmunoprecipitation experiments using native cell extracts (data not shown). To determine whether Mks1p interacts with Bmh1p, Bmh1p-myc was immunoprecipitated with anti- Figure 5D ). The loss-of-function mutant pro-The 14-3-3 Proteins Bmh1p and Bmh2p Negatively tein, Bmh1-1p, could not coprecipitate Mks1p (data not Regulate the RTG Pathway shown), suggesting that interaction between Mks1p and Yeast has two functionally redundant 14-3-3 proteins, Bmh1p is required to inhibit the retrograde pathway. Bmh1p and Bmh2p (Roberts et al., 1997) 
. Recently, van
To determine more precisely the relation between Heusden and Steensma (2001) identified mutations in Mks1p phosphorylation and its regulation of the RTG RTG3 and SIN4 as extragenic suppressors of bmh1 pathway, we compared the phosphorylation state of bmh2 mutations. To examine the effects of bmh1⌬ and Mks1p in bmh2⌬, rtg2⌬ bmh2⌬, bmh1⌬ bmh2⌬, and bmh2⌬ mutations on the RTG pathway, we used the rtg2⌬ bmh1⌬ bmh2⌬ cells. When the RTG pathway was ⌺1278b strain, which remains viable when both BMH1 repressed in cells grown in medium containing glutaand BMH2 are inactivated (Roberts et al., 1997) . Neither mate, Mks1p was more phosphorylated (Figure 5E,  the bmh1⌬ or bmh2⌬ mutant alone had a significant  lanes 2 and 3) . When the RTG pathway was inhibited, effect on CIT2-lacZ expression, whereas the bmh1⌬ as in rtg2⌬ cells, Mks1p was hyperphosphorylated (Fig-bmh2⌬ double mutant increased expression by about  ure 5E, lane 4) . In bmh1⌬bmh2⌬ cells, in which CIT2-40-fold ( Figure 5B ). This increased expression was en-lacZ reporter gene expression is high, Mks1p was largely tirely dependent on RTG3, indicating that effect of dephosphorylated, even when glutamate was included bmh1⌬ bmh2⌬ is due to activation of RTG3. Inactivation in the growth medium ( Figure 5E, lanes 5 and 6) . Toof RTG2 in bmh1⌬ bmh2⌬ cells reduced CIT2-lacZ exgether, these results are consistent with the prepression by only 44%, whereas in the bmh1⌬ or bmh2⌬ vious conclusion that hyperphosphorylation of Mks1p single mutants, inactivation of RTG2 completely abolis associated with downregulation of the RTG pathished CIT2-lacZ expression. These findings are similar way (Dilova et al., 2002; Sekito et al., 2002) . In the to the effects of the mks1⌬ (Dilova et al., 2002; Sekito  bmh1⌬bmh2⌬rtg2⌬ triple mutant, however, in which  et al., 2002; Tate et al., 2002) and the lst8-(2-5) mutations CIT2-lacZ expression is constitutively high, we observed (Liu et al., 2001) on RTG-dependent gene expression.  roughly equal amounts of phosphorylated and dephos-Moreover, like those mks1 and lst8 mutants, bmh1⌬ phorylated forms of Mks1p, and the addition of gluta-bmh2⌬ double mutants are also resistant to glutamate mate only slightly increased Mks1p phosphorylation repression of CIT2-lacZ expression (data not shown).
( Figure 5E, lanes 7 and 8) . It is likely therefore that in-The BMH1-1 mutation could not rescue the slow growth creased phosphorylation of Mks1p alone is not sufficient phenotype observed in bmh1⌬ bmh2⌬ cells (Roberts et to inhibit the RTG pathway, but that Mks1p must be bound to Bmh1p /Bmh2p.  al., 1997), indicating the BMH1-1 is a dominant-negative , is hyperphosphorylated, and is associated via its N-terminal domain with the 14-3-3 proteins, Bmh1p and Bmh2p. This is the proposed form of Mks1p responsible for downregulation of the RTG pathway. Rtg1p/Rtg3p export from the nucleus occurs through an Msn5p-dependent process (Komeili et al., 2000) . (B) Regions of sequence similarity between Mks1p and Ppz1p. Regions of amino acid identity are indicated in black, and regions of amino acid similarity are indicated in gray. -Aip1p (Figure 6 ). In the ab-Is Modulated by TOR Inhibition of the TOR kinases by rapamycin, or by growth sence of rapamycin, Mks1p is distributed in the cytoplasm of cells grown in rich medium. When cells were of cells on low-quality nitrogen sources, results in the Rtg2p-dependent nuclear accumulation of Rtg1p and treated for 90 min with 400 ng/ml rapamycin, Mks1p-GFP localized to cortical patches (Ͼ70% of total cells; Rtg3p and an increase in RTG-target gene expression that requires Rtg2p (Komeili et al., 2000) . To determine Figure 6, upper panels) , whereas in the control experiment with rapamycin-treated cells expressing Rtg2p not whether the activation of the RTG pathway by inhibition of the TOR kinases intersects with Rtg2p via its seques-fused with Aip1p, Mks1p-GFP remained distributed in the cytoplasm (Figure 6, lower panels) . These data indi-tration of Mks1p, we examined the effect of rapamycin cate that inhibition of TOR signaling results in the associ-Mks1p appears to be phosphorylated at multiple, and perhaps at different sites in the protein when the RTG ation of Mks1p with Rtg2p. pathway is inhibited by glutamate or in rtg2⌬ mutant cells. Thus, the regulation of Mks1p phosphorylation is Discussion likely to be complex. Point mutations within or near three conserved re-Regulation of the RTG Pathway by Rtg2p, gions of the N-terminal ATP binding domain of Rtg2p Mks1p, and Bmh1/2p result in inhibition of CIT2 reporter gene expression and Rtg2p positively regulates the retrograde signaling patha dramatic reduction in the ability of Rtg2p to bind way in response to the functional state of mitochondria, Mks1p. This compromised ability to bind Mks1p most nutritional cues, and TOR signaling. The present study likely accounts for the loss of CIT2 expression in those shows that Rtg2p control is executed through its revers-Rtg2p mutants. Although it is conceivable that the point ible association with a negative regulator of the retromutations may simply affect the binding interface begrade pathway, Mks1p. The inhibitory form of Mks1p tween Rtg2p and Mks1p, it is equally plausible that there is not bound to Rtg2p, but is complexed through its is a nucleotide requirement for the interaction between N-terminal domain with the 14-3-3 proteins, Bmh1p and Rtg2p and Mks1p. Rtg2p is related to the superfamily of Bmh2p. The inactive form of Mks1p is hypophosphoryproteins with an Hsp70/sugar kinase/actin ATP binding lated and bound to Rtg2p. A model depicting this reguladomain (Koonin, 1994) . Moreover, Rtg2p has sequence tory circuit is shown in Figure 7A . similarity to two bacterial phosphatases, PPX, an exopoly-We identified two domains of Mks1p that are crucial phosphatase and guanosine pentaphosphate phosphoto its regulation of the RTG pathway. The N-terminal hydrolase, GPPA, both of which contain the conserved domain from residues 1-304 contains the inhibitory dosequence blocks of the ATP binding pocket of the Hsp70 main of the protein and the C-terminal domain from family (Koonin, 1994) . Together, these findings raise the residues 276-584 functions to tether Mks1p to Rtg2p.
Interaction between Rtg2p and Mks1p treatment on the intracellular localization of Mks1p-GFP in cells expressing Rtg2p
intriguing possibility that Rtg2p may have a phospha-These conclusions are supported by the findings that tase activity. Based on the current findings, such an overexpression of the N-terminal domain inhibited CIT2 activity could be used in an adenine nucleotide-depenreporter gene expression in both wild-type and mks1⌬ dent manner to enable Rtg2p to bind to or dephoscells, whereas the C-terminal domain inhibited reporter phorylate Mks1p and prevent it from inhibiting the RTG gene expression only when overexpressed in wild-type pathway.
cells. Moreover, overexpression of Rtg2p in wild-type
The biochemical action of Mks1p is not known, but cells reversed the inhibition of reporter gene activity by several models are worthy of consideration. The most the C-terminal Mks1p fragment but not by the N-terminal obvious roles for Mks1p in the inhibition of the RTG fragment. These experiments suggest that the increased pathway would be to promote Rtg3p phosphorylation expression of Rtg2p sequesters the C-terminal fragment or to inhibit an Rtg3p-directed phosphatase activity. of Mks1p, preventing it from displacing endogenous, One or the other of those putative activities would prefull-length Mks1p from its association with Rtg2p. Fisumably be associated with the phosphorylated form nally, coimmunoprecipitation experiments showed that of Mks1p, bound to Bmh1p and Bmh2p. In either case, the C-but not the N-terminal domain of Mks1p coprecipsuch activities would keep Rtg3p hyperphosphorylated itates with Rtg2p. and sequestered together with Rtg1p in the cytoplasm. Using a similar rtg2⌬ bypass screen that previously Mks1p has no obvious conserved kinase or phosphayielded MKS1 and LST8 (Liu et al., 2001) , we identified tase domains, but it may be relevant that there are two a dominant BMH1-1 mutation, which, together with the regions of the protein, one in the N-terminal half and effects of a bmh1⌬ bmh2⌬ double mutant, revealed that the other in the C-terminal half, which have significant Bmh1p and Bmh2p function redundantly as negative sequence similarity to two domains of the Ser/Thr phosregulators of the RTG pathway. Because 14-3-3 proteins phatase, Ppz1p ( Figure 7B) . The phosphatase domain function by forming homo-and heterodimers, in many of Ppz1p, which is related to type I phosphatases, is cases interacting with phosphoserine residues of regulocated in the C-terminal region of the protein. The latory proteins (Tzivion and Avruch, 2002), it is probable N-terminal region, which contains the two domains of that the effect of the BMH1-1 mutation on the RTG pathsequence similarity with Mks1p, is unrelated to any way is due to formation of inactive Bmh1-1p/Bmh2p known phosphatases, but has been suggested to have heterodimers. The mutation to a stop codon of a highly a positive regulatory role in the phosphatase activity of conserved Trp at position 233 would be expected to Ppz1p (Clotet et al., 1996) the triple mutant, bmh1⌬ bmh2⌬ rtg2⌬, Mks1p in vivo, we developed an assay in which Rtg2p or Mks1p was redirected from its cytoplasmic localiza-appears to be hyperphosphorylated, that form is likely to exert its inhibitory effect on the RTG pathway only tion to actin cortical patches by fusing these regulatory proteins to the actin interacting protein, Aip1p. These when complexed with Bmh1p and Bmh2p. Altogether,
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Aip1p-tagged derivatives constitutively localize to corti-
The rtg2 point mutants were obtained from previous genetic screens cal patches, independent of the activity of RTG pathway. 
